| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1559 | 2020 |
| Persistence and evolution of SARS-CoV-2 in an immunocompromised host B Choi, MC Choudhary, J Regan, JA Sparks, RF Padera, X Qiu, ... New England Journal of Medicine 383 (23), 2291-2293, 2020 | 1249 | 2020 |
| Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination MJ Gorman, N Patel, M Guebre-Xabier, AL Zhu, C Atyeo, KM Pullen, ... Cell Reports Medicine 2 (9), 2021 | 110 | 2021 |
| Histoplasmosis-induced hemophagocytic syndrome: a case series and review of the literature JL Townsend, S Shanbhag, J Hancock, K Bowman, AE Nijhawan Open forum infectious diseases 2 (2), ofv055, 2015 | 79 | 2015 |
| Early cross-coronavirus reactive signatures of humoral immunity against COVID-19 P Kaplonek, C Wang, Y Bartsch, S Fischinger, MJ Gorman, K Bowman, ... Science immunology 6 (64), eabj2901, 2021 | 72 | 2021 |
| Therapeutic vaccination expands and improves the function of the HIV-specific memory T-cell repertoire JP Casazza, KA Bowman, S Adzaku, EC Smith, ME Enama, RT Bailer, ... The Journal of infectious diseases 207 (12), 1829-1840, 2013 | 66 | 2013 |
| Fecal microbiota transplantation: current clinical efficacy and future prospects KA Bowman, EK Broussard, CM Surawicz Clinical and experimental gastroenterology, 285-291, 2015 | 62 | 2015 |
| Hybrid immunity shifts the Fc-effector quality of SARS-CoV-2 mRNA vaccine-induced immunity KA Bowman, D Stein, S Shin, KG Ferbas, NH Tobin, C Mann, S Fischinger, ... MBio 13 (5), e01647-22, 2022 | 30 | 2022 |
| The kinetics of SARS-CoV-2 antibody development is associated with clearance of RNAemia C Wang, Y Li, P Kaplonek, M Gentili, S Fischinger, KA Bowman, ... MBio 13 (4), e01577-22, 2022 | 14 | 2022 |
| Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 counts M Mthembu, KA Bowman, LRL Davies, S Khuzwayo, L Mazibuko, ... EBioMedicine 90, 2023 | 10 | 2023 |
| Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cells JE Lemieux, A Li, M Gentili, CA Perugino, ZF Weiss, K Bowman, ... MedRxiv, 2021.07. 11.21260338, 2021 | 10 | 2021 |
| Serological markers of SARS-CoV-2 reinfection SM Siddiqui, KA Bowman, AL Zhu, S Fischinger, S Beger, JS Maron, ... MBio 13 (1), e02141-21, 2022 | 8 | 2022 |
| Distinguishing severe acute respiratory syndrome coronavirus 2 persistence and reinfection: a retrospective cohort study SE Turbett, CH Tomkins-Tinch, MN Anahtar, CM Dugdale, EP Hyle, ... Clinical Infectious Diseases 76 (5), 850-860, 2023 | 7 | 2023 |
| Age and sex influence antibody profiles associated with tuberculosis progression LRL Davies, C Wang, P Steigler, KA Bowman, S Fischinger, M Hatherill, ... Nature Microbiology 9 (6), 1513-1525, 2024 | 6 | 2024 |
| Understanding Fc function for rational vaccine design against pathogens KA Bowman, P Kaplonek, RP McNamara Mbio 15 (1), e03036-23, 2024 | 6 | 2024 |
| Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients—A Prospective … MY Liew, JI Mathews, A Li, R Singh, SA Jaramillo, ZF Weiss, K Bowman, ... Open Forum Infectious Diseases 10 (8), ofad369, 2023 | 5 | 2023 |
| Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity. mBio 0, e01647–22 KA Bowman, D Stein, S Shin, KG Ferbas, NH Tobin, C Mann, S Fischinger, ... | 3 | 2022 |
| Borrelia-specific antibody profiles and complement deposition in joint fluid distinguish antibiotic-refractory from-responsive Lyme arthritis KA Bowman, CD Wiggins, E DeRiso, S Paul, K Strle, JA Branda, ... Iscience 27 (2), 2024 | 1 | 2024 |
| Collaboration between the Fab and Fc Contribute to Maximal Protection Against SARS-CoV-2 Following NVX-CoV2373 Subunit Vaccine with Matrix-M™ Vaccination MJ Gorman, N Patel, M Guebre-Xabier, AL Zhu, C Atyeo, KM Pullen, ... | 1 | 2021 |
| Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... NEW ENGLAND JOURNAL OF MEDICINE 383 (24), 2333-2344, 2020 | 1 | 2020 |
